+ +

•  

   

     Western Blot analysis of A549 cells using SP-B Polyclonal Antibody    

  
  

Natriuretic peptide precursor B (NPPB) antibody is a specialized tool used in biomedical research to detect and analyze the expression of B-type natriuretic peptide (BNP), a hormone encoded by the NPPB gene. BNP is primarily synthesized and secreted by cardiac ventricular myocytes in response to myocardial stretching and volume overload. It plays a critical role in regulating blood pressure, fluid balance, and cardiovascular homeostasis by promoting vasodilation, natriuresis, and diuresis. Elevated BNP levels are clinically associated with heart failure, myocardial infarction, and other cardiac pathologies, making it a key biomarker for diagnosing and monitoring these conditions.

The NPPB antibody is widely employed in techniques such as immunohistochemistry (IHC), Western blotting, and enzyme-linked immunosorbent assays (ELISA) to localize and quantify BNP in tissue samples or biological fluids. Researchers use this antibody to study the molecular mechanisms underlying cardiovascular diseases, cardiac remodeling, and hypertrophic responses. It is also utilized in preclinical studies to evaluate therapeutic interventions targeting BNP pathways. Commercial NPPB antibodies are typically raised in host species like rabbits or mice using synthetic peptides or recombinant proteins as immunogens. Validation steps, including knockout controls and cross-reactivity assessments, ensure specificity. Despite its utility, variations in antibody performance across experimental conditions necessitate careful optimization. Overall, the NPPB antibody serves as a vital reagent in both basic research and clinical diagnostics, advancing our understanding of cardiovascular health and disease.